Skip to content

Study on the effectiveness and brain plasticity mechanism of transferring the contralateral C7 to ipsilateral C8 in the treatment of central hemiplegia

Study on the effectiveness and brain plasticity mechanism of transferring the contralateral C7 to ipsilateral C8 in the treatment of central hemiplegia

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078865
Enrollment
Unknown
Registered
2023-12-20
Start date
2023-12-31
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke upper limb paralysis

Interventions

surgery group:contralateral C7 nerve transfer to ipsilateral C8

Sponsors

Department of Hand Surgery, Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Spastic hemiplegia of one upper limb caused cerebral hemorrhage, cerebral infarction, traumatic brain injury, encephalitis, cerebral palsy, etc; 2) Preoperatively, shoulder elbow function was good (shoulder elbow spasm score below level 1, shoulder joint active range of motion above 130 degrees, elbow joint active range of motion above 90 degrees), severe wrist and finger flexor spasm: wrist flexion spasm, finger joint flexion spasm, and thumb adduction spasm reached the modified Ashworth scale level 3-4; 3) Preoperative palmar ulnar sensory decline (sensory score below S3, significant decrease or disappearance of pain, warmth, and tactile sensation, or two-point discrimination greater than 8mm); 4) Under the age of 60, with onset of illness for more than one year; Although the function of hemiplegic upper limbs has undergone formal rehabilitation training, there has been no significant improvement in the past six months, and the recovery has entered a plateau period; Has a desire for further recovery through surgery; 5) Preoperative evaluation confirmed normal cortical function on the healthy side. 6) Patient or guardian voluntarily agree to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Have serious systemic diseases, such as hypertension, heart disease symptoms, diabetes, undiagnosed liver diseases or disorders (based on serum liver enzyme test results), kidney diseases or renal dysfunction, severe anemia, history of deep vein thrombosis, pulmonary artery thrombosis or cerebrovascular accident, cancer; 2) Patients who cannot take care of themselves in daily life, such as those who cannot walk independently; 3) Recurrent acute bleeding or infarction; 4) Excluding flexor tendon contractures caused by forearm trauma and bone joint abnormalities; 5) Severe upper limb joint contracture or joint deformity on the affected side; 6) The patient suffers from severe, untreated neurological and psychiatric disorders that prevent normal communication; 7) Patients or their family members request cessation of surgery or treatment due to personal reasons.

Design outcomes

Primary

MeasureTime frame
active range of motion;Spasticity;

Secondary

MeasureTime frame
upper limb Fugl-Meyer score;HS scale;

Countries

China

Contacts

Public ContactYun-Dong Shen; Wen-Dong Xu

Department of Hand Surgery, Huashan Hospital, Fudan University

yundongshen@fudan.edu.cn+86 135 2460 2662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026